Tumor‐Selective and Chemical Activation Strategies for Nitrogen Mustard Prodrugs
Chemistry – A European Journal · 01.04.2026 · 32 (13)
DOI: 10.1002/chem.202503344 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemistry – A European Journal, online erschienen am 23.01.2026. Verfasst von Thilini Nimasha Fernando Ponnamperumage und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry and the Milwaukee Institute For Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA. Hauptthemen laut MEDLINE: Prodrugs, Neoplasms, Mechlorethamine, Nitrogen Mustard Compounds. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Nitrogen mustards are highly potent DNA‐alkylating agents, but their clinical utility is limited by systemic toxicity and poor tumor selectivity. Tumor‐selective prodrug strategies have emerged to address these challenges, enabling spatiotemporally controlled activation of otherwise inert precursors. These approaches exploit tumor‐specific cues such as hypoxia, acidic pH, elevated reactive oxygen species (ROS), and redox imbalance, to achieve precise payload release. Stimulus‐induced bond cleavage or structural transformation liberates the masked nitrogen mustard (NM) in situ, facilitating targeted DNA cross‐linking. This review highlights molecular design principles underlying diverse activation strategies, emphasizing scaffold modifications and linker chemistries tailored to cancer‐associated triggers. We also discuss integration with advanced delivery platforms, including polymeric carriers and nanoplatforms, to enhance tumor accumulation and therapeutic indices while minimizing off‐target toxicity. By consolidating recent advances, this review illustrates how bioorthogonal and tumor‐selective activation strategies, including those responsive to hypoxia, ROS, and pH, are redefining the precision oncology potential of NM prodrugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry and the Milwaukee Institute For Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA.
ORCID-Profile: Xiaohua Peng
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Ponnamperumage, T. N. F., Mahendran, M., Awoyera, W. O., Miller, C. J., Ali, T., Hill, D. E., Raschka, N. H., & Peng, X. (2026). Tumor‐Selective and Chemical Activation Strategies for Nitrogen Mustard Prodrugs. Chemistry – A European Journal, 32(13). https://doi.org/10.1002/chem.202503344
Vancouver
Ponnamperumage TNF, Mahendran M, Awoyera WO, Miller CJ, Ali T, Hill DE, et al. Tumor‐Selective and Chemical Activation Strategies for Nitrogen Mustard Prodrugs. Chemistry – A European Journal. 2026;32(13). doi:10.1002/chem.202503344
BibTeX
@article{Ponnamperumage2026,
author = {Ponnamperumage, Thilini Nimasha Fernando and Mahendran, Mayurika and Awoyera, Wasiu Olaniyi and Miller, Cody Joshua and Ali, Taufeeque and Hill, Dalton Edmund and Raschka, Natalie Hope and Peng, Xiaohua},
title = {Tumor‐Selective and Chemical Activation Strategies for Nitrogen Mustard Prodrugs},
journal = {Chemistry – A European Journal},
year = {2026},
volume = {32},
number = {13},
doi = {10.1002/chem.202503344}
}
EUVIMED